MCDD may exert its efficacy through the molecular mechanism of LCN-2/NF-κB, which provide a theoretical basis for the clinical application of MCDD and development of new therapeutic targets of PCOS-IR. Here, NFKB1 is linked to polycystic ovary syndrome.